TA-270
TA-270, a novel quinolinone derivative, is a potent inhibitor of 5-lipoxygenase that plays an important role in asthma research[1].
Product Specifications
CAS Number
[194037-25-7]
UNSPSC
12352005
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/ta-270.html
Smiles
O=C(NC1=CC2=C(C=C1)C(O)=C(OCCCCCCCC)C(N2C)=O)/C=C/C3=CC(OC)=C(O)C(OC)=C3
Molecular Formula
C29H36N2O7
Molecular Weight
524.61
References & Citations
[1]Y Aoki, et al. Inhibitory effect of a novel quinolinone derivative, TA-270, on asthmatic inflammatory responses in sensitized guinea pigs. Eur J Pharmacol. 2000 Dec 15;409 (3) :325-30.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-P162002-25MG 25 mg
1-Palmitoyl-2-oleoyl-3-linoleoyl-rac-glycerol-d5
Sign In for Pricing
View Details 
MBS6170109-02 5x 0.1 mL
RGMA (RGM Domain Family, Member A, RGM) (APC)
Sign In for Pricing
View Details 